Hartmann Dirk, Eickhoff Axel, Damian Ulrich, Riemann Juergen F, Schilling Dieter
Department of Medicine C (Gastroenterology), Academic Teaching Hospital of the Johannes-Gutenberg-University of Mainz, Ludwigshafen, Germany.
Eur J Gastroenterol Hepatol. 2007 Feb;19(2):133-7. doi: 10.1097/01.meg.0000252628.57925.32.
It has been demonstrated that therapy with proton pump inhibitors reduces recurrence of bleeding following initial endoscopic treatment of bleeding peptic ulcers.
This study compared the effects of esomeprazole 40 mg and pantoprazole 40 mg on intragastric acid control. Both substances were administered intravenously as 15-min infusion and as bolus injection.
Healthy men and women volunteers were enrolled in this single-center, open, randomized, three-way crossover study. After administration of esomeprazole 40 mg and pantoprazole 40 mg intravenously as 15-min infusion, and pantoprazole 40 mg intravenously as bolus injection, continuous 24-h intragastric pH monitoring was carried out.
pH data were available for 21 Helicobacter pylori-negative and seven H. pylori-positive volunteers. In H. pylori-negative volunteers, esomeprazole 40 mg intravenously resulted in 11.8 h with an intragastric pH>4 compared with 5.6 h for pantoprazole 40 mg intravenously as infusion (P<0.0001), and 7.2 h for pantoprazole 40 mg intravenously as bolus injection (P<0.001). During the first 6 h of administration, the corresponding values were 3.4, 1.1 (P<0.000001), and 2.1 h (P<0.001), respectively.
In H. pylori-negative patients, a single dose of esomeprazole 40 mg intravenously provides an intragastric acid control that is faster and more pronounced than administration of pantoprazole 40 mg intravenously.
已证实质子泵抑制剂治疗可降低消化性溃疡出血初次内镜治疗后出血的复发率。
本研究比较了40毫克埃索美拉唑和40毫克泮托拉唑对胃内酸控制的效果。两种药物均通过静脉15分钟输注和推注给药。
健康男性和女性志愿者参与了这项单中心、开放、随机、三交叉研究。分别静脉15分钟输注40毫克埃索美拉唑和40毫克泮托拉唑,以及静脉推注40毫克泮托拉唑后,进行连续24小时胃内pH监测。
有21名幽门螺杆菌阴性和7名幽门螺杆菌阳性志愿者的pH数据。在幽门螺杆菌阴性志愿者中,静脉注射40毫克埃索美拉唑使胃内pH>4的时间为11.8小时,而静脉输注40毫克泮托拉唑为5.6小时(P<0.0001),静脉推注40毫克泮托拉唑为7.2小时(P<0.001)。给药的前6小时,相应数值分别为3.4、1.1(P<0.000001)和2.1小时(P<0.001)。
在幽门螺杆菌阴性患者中,静脉注射单剂量40毫克埃索美拉唑比静脉注射40毫克泮托拉唑能更快、更显著地控制胃内酸。